Agarwala, V., Chandrakanth, M., Sharma, A., Dasgupta, A., Roy, M., Sen, N., . . . Nayak, H. (2026 Supplement 19). Real-world efficacy of cabozantinib in combination with pemetrexed and carboplatin followed by pemetrexed-cabozantinib maintenance as first-line therapy for metastatic KRAS-mutant lung adenocarcinoma. Journal of Clinical Oncology, 44, 278-305.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Agarwala, Vivek, et al. "Real-world Efficacy of Cabozantinib in Combination with Pemetrexed and Carboplatin Followed by Pemetrexed-cabozantinib Maintenance as First-line Therapy for Metastatic KRAS-mutant Lung Adenocarcinoma."
Journal of Clinical Oncology 44 (2026 Supplement 19): 278-305.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Agarwala, Vivek, et al. "Real-world Efficacy of Cabozantinib in Combination with Pemetrexed and Carboplatin Followed by Pemetrexed-cabozantinib Maintenance as First-line Therapy for Metastatic KRAS-mutant Lung Adenocarcinoma."
Journal of Clinical Oncology, vol. 44, 2026 Supplement 19, pp. 278-305.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.